Nines Overview

  • Founded
  • 2017
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 31
Employees
  • Latest Deal Type
  • M&A

Nines General Information

Description

Developer of teleradiology practice designed for radiologists to deliver the best patient care. The company's platform analyzes every scan for emergent findings that may require immediate attention, and highlight subtle findings to assist radiological review, providing patients with better care and accurate results.

Contact Information

Website
www.nines.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Primary Office
  • 329 Alma Street
  • Palo Alto, CA 94301
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Nines Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 18-Feb-2022 000.00 Completed Generating Revenue
3. Early Stage VC (Series A) 01-Dec-2020 000.00 000.00 000.00 Completed Generating Revenue
2. Early Stage VC (Series A) 22-Nov-2019 $16.5M $16.5M 000.00 Completed Startup
1. Seed Round 01-Jan-2017 Completed Startup
To view Nines’s complete valuation and funding history, request access »

Nines Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-4 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series A-3 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Series A-2 301,105 $0.000100 $0.03 $0.51 $0.51 1x $0.51 0.53%
Series A-1 3,945,983 $0.000100 $0.02 $0.26 $0.26 1x $0.26 6.9%
To view Nines’s complete cap table history, request access »

Nines Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of teleradiology practice designed for radiologists to deliver the best patient care. The company's platform a
Diagnostic Equipment
Palo Alto, CA
31 As of 2021
000.00
000000&0 000.00

0000000

sectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim
00000 0000000000 0000000000 0000000
Amsterdam, Netherlands
00 As of 0000
000.00
000000&0 000.00

0000000

it esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt
00000 0000000000 0000000000 0000000
Bangalore, India
000000&0
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Nines Competitors (4)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Aidence Formerly VC-backed Amsterdam, Netherlands 00 000.00 000000&0 000.00
0000000 0000000000 Formerly Accelerator/Incubator backed Bangalore, India 000000&0
0000 00000 Venture Capital-Backed Newton, MA 00 000.00 00000000000 000.00
0000000 0000000 Corporation Ridgefield, CT
To view Nines’s complete competitors history, request access »

Nines Executive Team (7)

Name Title Board Seat Contact Info
David Stavens Ph.D Chief Executive Officer
Max Ochoa JD Chief Financial Officer & General Counsel
Alexander Kagen MD Co-Founder & Chief Medical Officer
Michael Ovitz Advisor
Kimberly Hammonds Advisor
You’re viewing 5 of 7 executive team members. Get the full list »

Nines Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nines Former Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
8VC Venture Capital Minority 000 0000 000000 0
Accel Venture Capital Majority 000 0000 000000 0
Gaingels Venture Capital Minority 000 0000 000000 0
Kimberly Hammonds Angel (individual) Minority 000 0000 000000 0
Lori Goler Angel (individual) Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »